Literature DB >> 18038896

A new monoterpene glycoside from the roots of Paeonia lactiflora increases the differentiation of osteoblastic MC3T3-E1 cells.

Pham Hai Yen1, Phan Van Kiem, Nguyen Xuan Nhiem, Nguyen Huu Tung, Tran Hong Quang, Chau Van Minh, Jung Woo Kim, Eun Mi Choi, Young Ho Kim.   

Abstract

A new monoterpene glycoside, 6'-O-beta-D-glucopyranosylalbiflorin (1), and four known compounds; albiflorin (2), 6'-O-benzoylalbiflorin (3), paeoniflorin (4) and benzoyl paeoniflorin (5), were isolated from the methanolic extract of the roots of Paeonia lactiflora Pall.. Their chemical structures were completely elucidated using a combination of 2D NMR techniques (COSY, HMQC and HMBC) and HRESI-MS analyses. To investigate the bioactivities of these compounds, their effects on the differentiation of osteoblastic MC3T3-E1 cells were tested. Compound 1 (0.01-10 microM) significantly increased the alkaline phosphatase activity and nodules mineralization of MC3T3-E1 cells compared to those of the control (P<0.05). These results suggest that newly isolated compound 1 has a direct stimulatory effect on bone formation in vitro and may contribute to the prevention for osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038896     DOI: 10.1007/bf02980258

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

Review 1.  Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.

Authors:  Yue Zhuo; Meng Li; Qiyao Jiang; Hanzhong Ke; Qingchun Liang; Ling-Feng Zeng; Jiansong Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

2.  Simultaneous Determination of Nine Active Compounds of the Traditional Chinese Medicinal Prescription Shaoyao-Gancao-Tang and Analysis of the Relationship between Therapeutical Effect and Compatibility of Medicines.

Authors:  Guangwei Zhu; Guijun Zhang; Meng Wang; Jingjuan Wang; Weixin Zeng; Xiaomei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-06       Impact factor: 2.629

3.  An analysis of the combination frequencies of constituent medicinal herbs in prescriptions for the treatment of bone and joint disorder in Korean medicine: determination of a group of candidate prescriptions for universal use.

Authors:  Yoo Kyoung Han; Seo Yul Kim; Jae Young Ahn; Jin Ung Baek
Journal:  Integr Med Res       Date:  2017-09-19

4.  Chemical Constituents from Cimicifuga dahurica and Their Anti-Proliferative Effects on MCF-7 Breast Cancer Cells.

Authors:  Chu Thi Thanh Huyen; Bui Thi Thuy Luyen; Ghulam Jilany Khan; Ha Van Oanh; Ta Manh Hung; Hui-Jun Li; Ping Li
Journal:  Molecules       Date:  2018-05-04       Impact factor: 4.411

Review 5.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

6.  Palmul-Tang, a Korean Medicine, Promotes Bone Formation via BMP-2 Pathway in Osteoporosis.

Authors:  La Yoon Choi; Mi Hye Kim; Yeon Kyung Nam; Ju Hee Kim; Hea-Young Cho; Woong Mo Yang
Journal:  Front Pharmacol       Date:  2021-03-26       Impact factor: 5.810

7.  Rapid Determination of Isomeric Benzoylpaeoniflorin and Benzoylalbiflorin in Rat Plasma by LC-MS/MS Method.

Authors:  Chuanqi Zhou; Xiaoke Wang
Journal:  Int J Anal Chem       Date:  2017-05-08       Impact factor: 1.885

8.  Optimization of the Static Human Osteoblast/Osteoclast Co-culture System.

Authors:  James Jam Jolly; Kok-Yong Chin; Mohd Fozi Nur Farhana; Ekram Alias; Kien Hui Chua; Wan Nuraini Wan Hasan; Soelaiman Ima-Nirwana
Journal:  Iran J Med Sci       Date:  2018-03

9.  Albiflorin Promotes Osteoblast Differentiation and Healing of Rat Femoral Fractures Through Enhancing BMP-2/Smad and Wnt/β-Catenin Signaling.

Authors:  Jae-Hyun Kim; Minsun Kim; SooYeon Hong; Eun-Young Kim; Hyangsook Lee; Hyuk-Sang Jung; Youngjoo Sohn
Journal:  Front Pharmacol       Date:  2021-07-16       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.